» Authors » Ayana Yamashita

Ayana Yamashita

Explore the profile of Ayana Yamashita including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 222
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yamashita A, Kishimoto T, Hamada M, Nakajima N, Urabe D
J Agric Food Chem . 2020 Jan; 68(7):2124-2131. PMID: 31985223
Lignin acylated with acetate and/or -coumarate is common in many herbaceous plants. Herein, the biomimetic oxidation of γ-acylated monolignols with AgO was studied to understand the effect of γ-acyl groups...
2.
Osaka R, Nakano Y, Takasago Y, Fujita T, Yamashita A, Shiragami C, et al.
Acta Ophthalmol . 2019 Mar; 97(6):e896-e901. PMID: 30816643
Purpose: To measure retinal oxygen saturation (SO ) in eyes with branch retinal vein occlusion (BRVO). Methods: Retinal oximetry was performed using the Oxymap T1 retinal oximeter in 50 eyes...
3.
Ono A, Shiragami C, Manabe S, Takasago Y, Osaka R, Kobayashi M, et al.
Medicine (Baltimore) . 2018 Aug; 97(31):e11737. PMID: 30075585
The aim of this study was to investigate the efficacy of periodic intravitreal aflibercept (IVA) in exudative age-related macular degeneration, and to explore the predictive factors for visual outcome.This is...
4.
Shiragami C, Takasago Y, Osaka R, Kobayashi M, Ono A, Yamashita A, et al.
Am J Ophthalmol . 2018 Jun; 193:80-86. PMID: 29940168
Purpose: To evaluate the type 1 choroidal neovascularization (CNV) incidence and associated factors in eyes with central serous chorioretinopathy (CSC). Design: Retrospective case series. Methods: Records of 363 eyes (324...
5.
Takasago Y, Shiragami C, Kobayashi M, Osaka R, Ono A, Yamashita A, et al.
Retina . 2017 Dec; 39(2):296-302. PMID: 29190232
Purpose: To compare the areas of choriocapillaris (CC) nonperfusion and macular atrophy (MA) in treated exudative age-related macular degeneration. Methods: This was a prospective, observational, cross-sectional study. Forty-four eyes exhibiting...
6.
Osaka R, Manabe S, Miyoshi Y, Nakano Y, Yamashita A, Shiragami C, et al.
Graefes Arch Clin Exp Ophthalmol . 2017 Jul; 255(9):1743-1748. PMID: 28669042
Purpose: To investigate the prevalence and characteristics of paravascular inner retinal abnormalities in healthy eyes. Materials And Methods: In this prospective observational case series, we included 178 healthy eyes (178...
7.
Osaka R, Shiragami C, Ono A, Kobayashi M, Takasago Y, Yamashita A, et al.
Retina . 2017 May; 38 Suppl 1:S114-S122. PMID: 28541960
Purpose: To evaluate the clinical features of Type 1 idiopathic macular telangiectasia (IMT) followed up for 2 years. Methods: Forty-nine patients with unilateral Type 1 IMT were examined. Thirty-one IMT...
8.
Shiragami C, Miyake M, Fujiwara A, Morizane Y, Tsujikawa A, Yamashita A, et al.
Medicine (Baltimore) . 2017 Mar; 96(12):e6422. PMID: 28328847
Background: To evaluate the efficacy and safety of topical isopropyl unoprostone (IU) in treating macular atrophy in age-related macular degeneration (AMD) patients. Methods: Fifty-two AMD patients with macular atrophy were...
9.
Gomi F, Oshima Y, Mori R, Kano M, Saito M, Yamashita A, et al.
Retina . 2015 Apr; 35(8):1569-76. PMID: 25830698
Purpose: To compare the 1-year results of initial or deferred photodynamic therapy (PDT) combined with intravitreal ranibizumab (IVR) for eyes with polypoidal choroidal vasculopathy. Methods: Prospectively, 72 men with treatment-naive...
10.
Hosokawa M, Shiraga F, Yamashita A, Shiragami C, Ono A, Shirakata Y, et al.
Br J Ophthalmol . 2015 Feb; 99(8):1087-91. PMID: 25712826
Background: This study aims to evaluate the therapeutic effect of intravitreal aflibercept injection for polypoidal choroidal vasculopathy (PCV). Methods: Eighteen eyes of 17 consecutive patients with PCV received three consecutive...